The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cardiotoxicity of CPX-351 vs 7+3 in patients with untreated high-risk acute myeloid leukemia.
 
Joshua Mitchell
Consulting or Advisory Role - Bridgebio; Pfizer
Research Funding - Abbott Laboratories; Myocardial Solutions; Pfizer
 
Michael Pfeiffer
Consulting or Advisory Role - Ancora Heart
Speakers' Bureau - Abbott
Research Funding - BioVentrix (Inst)
 
John Boehmer
No Relationships to Disclose
 
John Gorcsan
Research Funding - Jazz Pharmaceuticals (Inst)
 
Nalina Dronamraju
Employment - Jazz Pharmaceuticals
Stock and Other Ownership Interests - Jazz Pharmaceuticals
 
Stefan Faderl
Employment - Jazz Pharmaceuticals
Stock and Other Ownership Interests - Jazz Pharmaceuticals
Honoraria - Jazz Pharmaceuticals
Travel, Accommodations, Expenses - Jazz Pharmaceuticals
 
Tara L. Lin
Research Funding - Aptevo Therapeutics (Inst); Astellas Pharma (Inst); Bio-Path Holdings, Inc (Inst); Celyad (Inst); CicloMed (Inst); Cleave Biosciences (Inst); Jazz Pharmaceuticals (Inst)
 
Geoffrey L. Uy
Consulting or Advisory Role - Jazz Pharmaceuticals; Novartis
 
Jeffrey E. Lancet
Stock and Other Ownership Interests - Arvinas (I)
Consulting or Advisory Role - Abbvie; BerGenBio; Boxer Capital; Bristol-Myers Squibb/Celgene; Daiichi Sankyo; ElevateBio; Jazz Pharmaceuticals; Medtalks; Millennium; Novartis; RW Baird; Servier/Pfizer; The Dedham Group
 
Jorge E. Cortes
Consulting or Advisory Role - Bio-Path Holdings, Inc; Bristol-Myers Squibb; Centessa Pharmaceuticals; Gilead Sciences; Menarini; Novartis; Pfizer; Takeda
Research Funding - Abbvie/Genentech (Inst); Actuate Therapeutics (Inst); Astellas Pharma (Inst); Bio-Path Holdings, Inc (Inst); Bristol-Myers Squibb (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst); Pfizer (Inst); Sellas Life Sciences (Inst); Sun Pharma (Inst); Takeda (Inst)